Repare Shareholders Approve Acquisition by XenoTherapeutics, Inc.

Core Viewpoint - Repare Therapeutics Inc. has received shareholder approval for its acquisition by XenoTherapeutics, Inc. and Xeno Acquisition Corp. [1] Group 1 - The acquisition involves all issued and outstanding common shares of Repare Therapeutics [1] - XenoTherapeutics is identified as a non-profit biotechnology company [1]